Welcome: Guest | Site Use Options | Register | Login |

Celgene Corporation

86 Morris Avenue
Summit, NJ 07901
 Synopsis: Business Condition
Year Founded 1986
Employment 7,000
Sector Healthcare
Industry Biotechnology
Celgene Corporation
     Last modified on: 10/14/16

Spun out as independent company from the Celanese Corporation when the latter merged with American Hoechset in 1986, Celgene Corporation is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. Products marketed include REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, ankylosing spondylitis, Behçet's disease, atopic dermatitis, and ulcerative colitis. The company?s products also include VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); THALOMID for the patients with multiple myeloma and erythema nodosum leprosum;


Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920